Sanara MedTech Inc (SMTI)
27.62
-0.08
(-0.29%)
USD |
NASDAQ |
Jul 03, 16:00
Sanara MedTech Research and Development Expense (Annual): 4.132M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 4.132M |
December 31, 2022 | 3.367M |
Date | Value |
---|---|
December 31, 2021 | 0.5587M |
December 31, 2020 | 0.0402M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
0.0402M
Minimum
2020
4.132M
Maximum
2023
2.025M
Average
1.963M
Median
Research and Development Expense (Annual) Benchmarks
AptarGroup Inc | -- |
Daxor Corp | -- |
Precision Optics Corp Inc | 0.9924M |
Warby Parker Inc | -- |
Perspective Therapeutics Inc | 21.31M |